Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?

20248 citationsReviewgreen Open Access

Authors

Good health and well-being

Published in: Blood Reviews

Volume 65, pp. 101184-101184

Field-Weighted Citation Impact: 3.67